Patients Suffering Due to Lack of Branded Drugs

by Kathy Jones on September 4, 2010 at 8:32 PM
 Patients Suffering Due to Lack of Branded Drugs

The Chemist and Druggist Stock Survey 2010 has found that many pharmacists are finding it difficult to stock branded medicines.

This in turn is hurting the health of patients, UK experts have warned. It has emerged that drugs intended for sale in the UK are being exported to take advantage of the exchange rates, forcing patients to wait for long until their prescriptions are filled.


Some of the drugs that are most difficult to obtain include Parkinson's drug Sinemet, breast cancer drug Femara, schizophrenia medicine Zyprexa and the anti-depressant Cipralexare.

Richard Barker, director general of Association of the British Pharmaceutical Industry said there is a need for urgent action on this front, "Manufacturers have supplied more than enough medicines to satisfy patient demand in the UK but there is still not enough getting through to the front line."

The survey also said that 60% of pharmacists were braced for a worse 2011, while 90% said they spent at least one hour per week trying to find the drugs. 

Source: Medindia
Font : A-A+



Recommended Readings

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Patients Suffering Due to Lack of Branded Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests